Blood-Borne Diseases

A multifaceted intervention has tripled the rate of hepatitis C virus screening in a baby boomer population.

DONATE-HCV trial offers new hope to those on waiting lists for new hearts and/or lungs.

As Ebola case counts continue to climb in the ongoing outbreak, emergency preparedness simulations are underway in Uganda.

Designated frontline hospitals were expected to identify, isolate, and hold an Ebola patient for 12-24 hours, but an analysis cites gaps in biopreparedness in these facilities.

Ebola virus survivors experience ongoing symptoms following infection, and a new study tracks how those patients compare in health with close contacts who weren’t infected.

In May 2017, a case of hepatitis A was detected in a Salt Lake County hospital. Over the next 20 months, Utah health officials worked to address what ended up being the largest hepatitis A outbreak in the state’s history.

On any given day 590,000 individuals are incarcerated across the EU, yet surveillance and reporting for new infectious disease diagnoses are only required for tuberculosis.

Donald Jensen, MD, discusses the hepatitis A outbreaks that have been declared in 18 states since 2017, highlighting modes of transmission, vaccine recommendations, and the implications of co-infections.

Direct-acting antivirals are probably worth the price, but are there new ways to get them into patients’ hands?

A London study shows that men infected with HIV are acquiring HCV at much lower levels than before.

The first study to evaluate the cost-effectiveness of hepatitis C virus (HCV) screening among pregnant women in the US in the era of direct-acting antiviral (DAA) treatment demonstrates that it would be "highly" cost effective, even in states with low HCV prevalence.

Violence in the Democratic Republic of Congo has complicated public health efforts and overshadowed strides made in the response to the Ebola outbreak there.

UK study in Addiction identifies benefits for controversial programs proposed as a solution for the ongoing opioid crisis.

A new study reports that many health care workers had the ability to neutralize the Ebola virus, despite never exhibiting symptoms of infection.

Investigators have detected the presence of Ebola in a bat in Liberia, revealing more about how bats serve as reservoirs for the deadly pathogen.

A new analysis sheds light on what is needed to hit this benchmark.

Women living in or traveling to Africa and the Middle East should take precautions and avoid contact with mosquitoes and livestock.

Melvin Weinstein MD, discusses the emerging technologies that will advance the field of blood culture testing.

Kenneth Sherman, MD, discusses hepatitis B infections in immunocompromised patients and what clinicians should expect to see in the future for hepatitis B treatment.

Even when men who have sex with men are aware of the risk of hepatitis C infection, they aren’t always confident in their ability to go against the expectations of their peer group.

A new report shows improvement in some areas but a vast gap in US health care readiness still exists.

What’s happening in the African nation is only the latest example of the catch-22 caused by political unrest and infectious disease outbreaks.

Investigators have identified Marburg virus in Sierra Leone bats, marking the first time the hemorrhagic fever has been discovered in West Africa.

Patients with the hepatitis C virus who are on Medicaid in Oregon can expect to receive curative treatment in 2019, without having to wait for liver damage to set in.

We've compiled a list of the top 9 infectious disease outbreaks of 2019.

Successful treatment of recently acquired hepatitis C virus infection in 8 weeks, with a regimen currently approved for 12 weeks, could enable shorter, less costly treatment.

New findings on the ways Ebola proteins connect with human proteins may lead to a novel treatment for Ebola virus infections.

A lack of funding is currently hindering response where it’s needed most; the supply of clean water and sanitation.

Through retrospective analysis, investigators have identified a second case of rat hepatitis E virus in a human, which has close genetic relation to the first case.

A new trial evaluating the efficacy of investigational therapeutics mAb114, remdesivir, and ZMapp has launched in the Democratic Republic of the Congo.